Targeting rtPA in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the IST-3 trial

BACKGROUND AND PURPOSE: Intravenous rtPA, despite a risk of early symptomatic intracranial hemorrhage (SICH), is of net clinical benefit to acute stroke patients. We tested if predictive models could identify patients least likely to be harmed by SICH or those who gained no net benefit. METHODS: We...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stroke
Asıl Yazarlar: Whiteley, William N., Thompson, Douglas, Murray, Gordon, Cohen, Geoff, Lindley, Richard I., Wardlaw, Joanna, Sandercock, Peter
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282175/
https://ncbi.nlm.nih.gov/pubmed/24603072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.113.004362
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller